Page 110 - Read Online

Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg JC. Recent advances in the treatment of melanoma with BRAF and
M, Barker FG 2nd, Gill CM, Van Hummelen P, Thorner AR, Johnson MEK inhibitors. Ann Transl Med 2015;3:207.
BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin 105. Cancer Genome Atlas Network. Genomic Classification of Cutaneous
NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway Melanoma. Cell 2015;161:1681-96.
L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, 106. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and
Louis DN, Getz G, Hahn WC. Genomic Characterization of Brain metastasis: a role for epithelial-mesenchymal transition? Cancer Res
Metastases Reveals Branched Evolution and Potential Therapeutic 2005;65:5991-5.
Targets. Cancer Discov 2015;5:1164-77. 107. Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G,
96. Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu Wierinckx A, Saldanha G, Osborne J, Hutchinson P, Tse G, Lachuer
B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, J, Puisieux A, Pringle JH, Ansieau S, Tulchinsky E. A switch in the
Giuliano AE, Cui X. FOXC1 is a potential prognostic biomarker expression of embryonic EMT-inducers drives the development of
with functional significance in basal-like breast cancer. Cancer Res malignant melanoma. Cancer Cell 2013;24:466-80.
2010;70:3870-6. 108. Van Roy F. Beyond E-cadherin: roles of other cadherin superfamily
97. Sizemore ST, Keri RA. The forkhead box transcription factor FOXC1 members in cancer. Nat Rev Cancer 2014;14:121-34.
promotes breast cancer invasion by inducing matrix metalloprotease 109. Wilmott JS, Haydu LE, Menzies AM, Lum T, Hyman J, Thompson JF,
7 (MMP7) expression. J Biol Chem 2012;287:24631-40. Hersey P, Kefford RF, Scolyer RA, Long GV. Dynamics of chemokine,
98. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff cytokine, and growth factor serum levels in BRAF-mutant melanoma
SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson patients during BRAF inhibitor treatment. J Immunol 2014;192:2505-13.
MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, 110. Robertson GP. Functional and therapeutic significance of Akt deregulation
Toner M, Haber DA, Maheswaran S. Circulating breast tumor cells in malignant melanoma. Cancer Metastasis Rev 2005;24:273-85.
exhibit dynamic changes in epithelial and mesenchymal composition. 111. Stahl JM, Cheung M, Sharma A, Trivedi NR, Shanmugam S,
Science 2013;339:580-4. Robertson GP. Loss of PTEN promotes tumor development in
99. Miller AJ, Mihm MC, Jr. Melanoma. N Engl J Med 2006;355:51-65. malignant melanoma. Cancer Res 2003;63:2881-90.
100. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new 112. Mumford BS, Robertson GP. Circulating melanoma cells in the
concepts and evolving paradigms. Oncogene 2014;33:2413-22. diagnosis and monitoring of melanoma: an appraisal of clinical
101. The International Agency for Research on Cancer. Pathology and potential. Mol Diagn Ther 2014;18:175-83.
Genetics of Skin Tumours (IARC WHO Classification of Tumours). 113. Lin Q, Balasubramanian K, Fan D, Kim SJ, Guo L, Wang H, Bar-Eli
Lyon: IARC Press; 2006. M,Aldape KD, Fidler IJ. Reactive astrocytes protect melanoma cells
102. Fidler IJ. The Biology of brain metastasis: challenges for therapy. from chemotherapy by sequestering intracellular calcium through
Cancer J 2015;21:284-93. gap junction communication channels. Neoplasia 2010;12:748-54.
103. Berghoff AS, Preusser M. BRAF alterations in brain tumours: 114. Wilhelm I, Krizbai IA. In vitro models of the blood-brain barrier for
molecular pathology and therapeutic opportunities. Curr Opin Neurol the study of drug delivery to the brain. Mol Pharm 2014;11:1949-63.
2014;27:689-96. 115. Hopkins AM, DeSimone E, Chwalek K, Kaplan DL. 3D in vitro modeling
104. Muñoz-Couselo E, García JS, Pérez-García JM, Cebrián VO, Castán of the central nervous system. Prog Neurobiol 2015;125:1-25.

100
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ March 11, 2016 ¦